Cart
sales@molnova.com
PJ34
CAS No. 344458-19-1
PJ34( —— )
Catalog No. M18454 CAS No. 344458-19-1
PJ34 HCl is the hydrochloride salt of PJ34, which is a PARP inhibitor with EC50 of 20 nM and is equally potent to PARP1/2.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 43 | In Stock |
|
| 25MG | 80 | In Stock |
|
| 50MG | 133 | In Stock |
|
| 100MG | 215 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePJ34
-
NoteResearch use only, not for human use.
-
Brief DescriptionPJ34 HCl is the hydrochloride salt of PJ34, which is a PARP inhibitor with EC50 of 20 nM and is equally potent to PARP1/2.
-
DescriptionPJ34 HCl is the hydrochloride salt of PJ34, which is a PARP inhibitor with EC50 of 20 nM and is equally potent to PARP1/2.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorPARP1| PARP2
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number344458-19-1
-
Formula Weight295.34
-
Molecular FormulaC17H17N3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : 30 mg/mL 101.58 mM
-
SMILESCN(C)CC(=O)Nc1cc2c([nH]c(=O)c3ccccc23)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Garcia Soriano F, et al. Nat Med, 2001, 7(1), 108-113.
molnova catalog
related products
-
(3E,8Z,11Z)-Tetradec...
(3E,8Z,11Z)-Tetradeca-3,8,11-trienyl acetate ((3e,8z,11z)-Tetradecatrienyl Acetate) is an additive for tobacco products and a vegetable pest pheromone that can be used to capture pests in agriculture.
-
(2E)-3-(3,5-dimethox...
(2E)-3-(3,5-dimethoxyphenyl)-1-(2-methoxyphenyl)prop-2-en-1-one is a chemical compound.
-
3,4,5-Tricaffeoylqui...
3,4,5-Tricaffeoylquinic acid may attenuate the TNF-α±- and LPS-stimulated production of inflammatory mediators in keratinocytes by suppressing the Toll-like receptor 4 expression-mediated activation of the Akt, ERK and NF-κB pathways, it may exert an inhibitory effect against the pro-inflammatory mediator-induced skin disease.
